Advanced Drug Delivery Reviews logo Elsevier logo

Publisher: Elsevier

Volume 54, Number 4, 17 June 2002
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Introduction and overview of peptide and protein pegylation
pp. 453-456(4)

The origin of pegnology
pp. 457-458(2)
Author: Davis F.F.

Chemistry for peptide and protein PEGylation
pp. 459-476(18)
Authors: Roberts M.J.; Bentley M.D.; Harris J.M.

Mono-N-terminal poly(ethylene glycol)-protein conjugates
pp. 477-485(9)
Authors: Kinstler O.; Molineux G.; Treuheit M.; Ladd D.; Gegg C.

Enzymatic procedure for site-specific pegylation of proteins
pp. 487-504(18)
Author: Sato H.

Effects of PEG conjugation on insulin properties
pp. 505-530(26)
Authors: Hinds K.D.; Kim S.W.

PEGylated antibodies and antibody fragments for improved therapy: a review
pp. 531-545(15)
Author: Chapman A.P.

Structural and biological characterization of pegylated recombinant interferon alpha-2b and its therapeutic implications
pp. 547-570(24)
Authors: Wang Y.-S.; Youngster S.; Grace M.; Bausch J.; Bordens R.; Wyss D.F.

Use of peginterferon alfa-2a (40 KD) (Pegasys(R)) for the treatment of hepatitis C
pp. 571-586(16)
Authors: Rajender Reddy K.; Modi M.W.; Pedder S.

Polyethylene glycol-superoxide dismutase, a conjugate in search of exploitation
pp. 587-606(20)
Authors: Veronese F.M.; Caliceti P.; Schiavon O.; Sergi M.

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A